These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

590 related items for PubMed ID: 21238884

  • 1. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U, Bellis L, Puoti C, Burroughs AK.
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [Abstract] [Full Text] [Related]

  • 2. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!
    Merkel C, Montagnese S.
    Eur J Intern Med; 2011 Feb; 22(1):1-4. PubMed ID: 21238883
    [Abstract] [Full Text] [Related]

  • 3. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J.
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [Abstract] [Full Text] [Related]

  • 4. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C, Aracil C, Colomo A, Hernández-Gea V, López-Balaguer JM, Alvarez-Urturi C, Torras X, Balanzó J, Guarner C.
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [Abstract] [Full Text] [Related]

  • 5. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R, Escorsell A, Garcia-Pagan JC, Makuch R, Patch D, Matloff DS, Bosch J, Portal Hypertension Collaborative Group.
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V, Abraldes JG, Raffa S, Retto O, Berzigotti A, García-Pagán JC, Bosch J.
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [Abstract] [Full Text] [Related]

  • 7. Measurement of portal pressure.
    Abraldes JG, Sarlieve P, Tandon P.
    Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
    [Abstract] [Full Text] [Related]

  • 8. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 9. Preventing first variceal hemorrhage in cirrhosis.
    Albillos A.
    J Clin Gastroenterol; 2007 May; 41 Suppl 3():S305-11. PubMed ID: 17975481
    [Abstract] [Full Text] [Related]

  • 10. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY, Baik SK, Suk KT, Yea CJ, Lee IY, Kim JW, Cha SH, Kim YJ, Um SH, Han KH.
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [Abstract] [Full Text] [Related]

  • 11. [Portal pressure should be measured on suspicion of portal hypertension].
    Møller S, Bendtsen F.
    Ugeskr Laeger; 2010 Dec 06; 172(49):3411-3. PubMed ID: 21129318
    [Abstract] [Full Text] [Related]

  • 12. Steatosis and portal hypertension.
    Puoti C, Bellis L.
    Eur Rev Med Pharmacol Sci; 2005 Dec 06; 9(5):285-90. PubMed ID: 16231591
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C, Bolognesi M, Berzigotti A, Amodio P, Cavasin L, Casarotto IM, Zoli M, Gatta A.
    J Hepatol; 2010 Jan 06; 52(1):45-53. PubMed ID: 19914730
    [Abstract] [Full Text] [Related]

  • 14. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
    Li S, Feng H, Zhu J, Zhong C, Leng X, Du R.
    Zhonghua Wai Ke Za Zhi; 2000 Apr 06; 38(4):287-90. PubMed ID: 12828169
    [Abstract] [Full Text] [Related]

  • 15. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C.
    J Clin Gastroenterol; 2007 Apr 06; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [Abstract] [Full Text] [Related]

  • 16. Value of the hepatic venous pressure gradient to monitor drug therapy for portal hypertension: a meta-analysis.
    Albillos A, Bañares R, González M, Ripoll C, Gonzalez R, Catalina MV, Molinero LM.
    Am J Gastroenterol; 2007 May 06; 102(5):1116-26. PubMed ID: 17391317
    [Abstract] [Full Text] [Related]

  • 17. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA, Procopet B, Métivier S, Péron JM, Selves J, Vinel JP, Bureau C.
    J Hepatol; 2011 Nov 06; 55(5):1017-24. PubMed ID: 21354450
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW, Kalk JF, Klein CP.
    Hepatology; 1999 Feb 06; 29(2):334-9. PubMed ID: 9918907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.